InfraTrac, Inc

InfraTrac, Inc. is a woman-owned technology company that specializes in light-based innovation for anti-counterfeiting, quality assurance, and controlled release applications. Founded in 2006, the company leverages near-infrared (NIR) spectroscopy and light-activated chemical signatures to provide authentication solutions. Its technology is designed to verify the integrity of products by comparing them against chemometric reference models, which is particularly useful for additive manufacturing. By analyzing how materials respond to light, InfraTrac provides a non-destructive, rapid, and precise method to confirm that products meet specified standards without requiring extensive operator training.

This technology is utilized across industries including pharmaceuticals and aerospace, where ensuring material authenticity and quality is critical. In the pharmaceutical sector, for instance, the company provides tools for hospital pharmacies to verify that 3D-printed doses contain the correct concentrations of active ingredients, helping to prevent the administration of non-conforming medication. InfraTrac has received competitive funding and contracts from organizations such as the National Institutes of Health (NIH), the National Institute of Standards and Technology (NIST), and Lockheed Martin to advance its spectroscopic quality and authentication capabilities. The company continues to innovate in the development of 3D-printed nano-scale containers aimed at improving the controlled release of payloads for medical and industrial applications.